Balance Sheet
Cash Flow Statement
Amortization of GoodwillCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amn Healthcare Services (AMN) Asset Writedowns and Impairment: 2009-2021

Historic Asset Writedowns and Impairment for Amn Healthcare Services (AMN) over the last 13 years, with FY2021 value amounting to $158000.0.

  • Amn Healthcare Services' Asset Writedowns and Impairment changed N/A to $158000.0 in Q1 2021 from the same period last year, while for Dec 2021 it was $158000.0, marking a year-over-year decrease of 9681.19%. This contributed to the annual value of $158000.0 for FY2021, which is 9681.19% down from last year.
  • Amn Healthcare Services' Asset Writedowns and Impairment amounted to $158000.0 in FY2021, which was down 9681.19% from $5.0 million recorded in FY2020.
  • In the past 5 years, Amn Healthcare Services' Asset Writedowns and Impairment registered a high of $10.3 million during FY2017, and its lowest value of $158000.0 during FY2021.
  • In the last 5 years, Amn Healthcare Services' Asset Writedowns and Impairment had a median value of $6.3 million in 2019 and averaged $6.1 million.
  • In the last 5 years, Amn Healthcare Services' Asset Writedowns and Impairment plummeted by 1289.29% in 2018 and then plummeted by 9681.19% in 2021.
  • Annual analysis of 5 years shows Amn Healthcare Services' Asset Writedowns and Impairment stood at $10.3 million in 2017, then fell by 12.89% to $9.0 million in 2018, then crashed by 30.32% to $6.3 million in 2019, then decreased by 21.02% to $5.0 million in 2020, then tumbled by 96.81% to $158000.0 in 2021.
  • Its Asset Writedowns and Impairment stands at $158000.0 for FY2021, versus $5.0 million for FY2020 and $6.3 million for FY2019.